Literature DB >> 12204943

Laboratory diagnosis of visceral leishmaniasis.

Shyam Sundar1, M Rai.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12204943      PMCID： PMC120052          DOI： 10.1128/cdli.9.5.951-958.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


× No keyword cloud information.
  76 in total

1.  Evaluation of PCR for diagnosis of visceral leishmaniasis.

Authors:  O F Osman; L Oskam; E E Zijlstra; N C Kroon; G J Schoone; E T Khalil; A M El-Hassan; P A Kager
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

Review 2.  Leishmania and human immunodeficiency virus coinfection: the first 10 years.

Authors:  J Alvar; C Cañavate; B Gutiérrez-Solar; M Jiménez; F Laguna; R López-Vélez; R Molina; J Moreno
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

3.  Diagnosis of visceral leishmaniasis by the polymerase chain reaction using blood, bone marrow and lymph node samples from patients from the Sudan.

Authors:  K Andresen; S Gasim; A M Elhassan; E A Khalil; D C Barker; T G Theander; A Kharazmi
Journal:  Trop Med Int Health       Date:  1997-05       Impact factor: 2.622

4.  Detection of Leishmania in the blood of early kala-azar patients with the aid of the polymerase chain reaction.

Authors:  S Adhya; M Chatterjee; M Q Hassan; S Mukherjee; S Sen
Journal:  Trans R Soc Trop Med Hyg       Date:  1995 Nov-Dec       Impact factor: 2.184

5.  rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis.

Authors:  R Badaró; D Benson; M C Eulálio; M Freire; S Cunha; E M Netto; D Pedral-Sampaio; C Madureira; J M Burns; R L Houghton; J R David; S G Reed
Journal:  J Infect Dis       Date:  1996-03       Impact factor: 5.226

6.  Kala-azar: a comparative study of parasitological methods and the direct agglutination test in diagnosis.

Authors:  E E Zijlstra; M S Ali; A M el-Hassan; I A el-Toum; M Satti; H W Ghalib; P A Kager
Journal:  Trans R Soc Trop Med Hyg       Date:  1992 Sep-Oct       Impact factor: 2.184

7.  Leishmania donovani: titration of antibodies to the fucose-mannose ligand as an aid in diagnosis and prognosis of visceral leishmaniasis.

Authors:  C B Palatnik-de-Sousa; E M Gomes; E Paraguai-de-Souza; M Palatnik; K Luz; R Borojevic
Journal:  Trans R Soc Trop Med Hyg       Date:  1995 Jul-Aug       Impact factor: 2.184

8.  Diagnostic and prognostic value of K39 recombinant antigen in Indian leishmaniasis.

Authors:  S Singh; A Gilman-Sachs; K P Chang; S G Reed
Journal:  J Parasitol       Date:  1995-12       Impact factor: 1.276

9.  Post kala-azar dermal leishmaniasis: a neglected aspect of kala-azar control programmes.

Authors:  C P Thakur; K Kumar
Journal:  Ann Trop Med Parasitol       Date:  1992-08

10.  Epidemic visceral leishmaniasis in southern Sudan: treatment of severely debilitated patients under wartime conditions and with limited resources.

Authors:  J Seaman; A J Mercer; H E Sondorp; B L Herwaldt
Journal:  Ann Intern Med       Date:  1996-04-01       Impact factor: 25.391
View more
  140 in total

Review 1.  Systematic review of biomarkers to monitor therapeutic response in leishmaniasis.

Authors:  Anke E Kip; Manica Balasegaram; Jos H Beijnen; Jan H M Schellens; Peter J de Vries; Thomas P C Dorlo
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Utility of the microculture method in non-invasive samples obtained from an experimental murine model with asymptomatic leishmaniasis.

Authors:  Adil M Allahverdiyev; Malahat Bagirova; Rabia Cakir-Koc; Serhat Elcicek; Olga Nehir Oztel; Sezen Canim-Ates; Emrah Sefik Abamor; Serap Yesilkir-Baydar
Journal:  Am J Trop Med Hyg       Date:  2012-07       Impact factor: 2.345

3.  Evaluation of two rK39 dipstick tests, direct agglutination test, and indirect fluorescent antibody test for diagnosis of visceral leishmaniasis in a new epidemic site in highland Ethiopia.

Authors:  Carmen Cañavate; Merce Herrero; Javier Nieto; Israel Cruz; Carmen Chicharro; Pilar Aparicio; Abate Mulugeta; Daniel Argaw; Anna J Blackstock; Jorge Alvar; Caryn Bern
Journal:  Am J Trop Med Hyg       Date:  2011-01       Impact factor: 2.345

Review 4.  Diagnosis of visceral leishmaniasis.

Authors:  Pankaj Srivastava; Anand Dayama; Sanjana Mehrotra; Shyam Sundar
Journal:  Trans R Soc Trop Med Hyg       Date:  2010-11-11       Impact factor: 2.184

5.  Active and passive case detection strategies for the control of leishmaniasis in Bangladesh.

Authors:  A K Das; A D Harries; S G Hinderaker; R Zachariah; B Ahmed; G N Shah; M A Khogali; G I Das; E M Ahmed; K Ritmeijer
Journal:  Public Health Action       Date:  2014-03-21

6.  Asymptomatic Leishmania infection: a new challenge for Leishmania control.

Authors:  Om Prakash Singh; Epco Hasker; David Sacks; Marleen Boelaert; Shyam Sundar
Journal:  Clin Infect Dis       Date:  2014-02-27       Impact factor: 9.079

7.  The efficacy of L. (L.) chagasi excreted-secreted antigens (ESAs) for visceral leishmaniasis diagnosis is due to low levels of cross-reactivity.

Authors:  Viviana Pinedo-Cancino; Norival Kesper; Clara Lúcia Barbiéri; José Angelo Lauletta Lindoso; Eufrosina Setsu Umezawa
Journal:  Am J Trop Med Hyg       Date:  2013-01-16       Impact factor: 2.345

8.  ELISA and western blotting for the detection of Hsp70 and Hsp83 antigens of Leishmania donovani.

Authors:  Jaspreet Kaur; Sukhbir Kaur
Journal:  J Parasit Dis       Date:  2012-07-03

9.  Comparative evaluation of blood and serum samples in rapid immunochromatographic tests for visceral leishmaniasis.

Authors:  Dinesh Kumar; Basudha Khanal; Puja Tiwary; Shyam Lal Mudavath; Narendra K Tiwary; Rupa Singh; Kanika Koirala; Marleen Boelaert; Suman Rijal; Shyam Sundar
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

10.  Leishmania promastigote membrane antigen-based enzyme-linked immunosorbent assay and immunoblotting for differential diagnosis of Indian post-kala-azar dermal leishmaniasis.

Authors:  Samiran Saha; Tuhina Mazumdar; Khairul Anam; Rajesh Ravindran; Bibhas Bairagi; Bibhuti Saha; Ramapada Goswami; Netai Pramanik; Subhashis K Guha; Sourjya Kar; Dwijadas Banerjee; Nahid Ali
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.